FSD Pharma Issues Corporate Updates
DENVER, Colo., April 06, 2022--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a ...
DENVER, Colo., April 06, 2022--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company"), a ...
DENVER, Colo., February 25, 2022 – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), ...
New Website Shares FSD’s Unique Drug Pipeline and Vision to Improve the Quality of Life for Patients Suffering from Brain ...
DENVER, Colo., December 2nd , 2021 – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Pharma” or the ...
Lucid Adds Potential for Neurodegenerative Disease Treatments and Mental Health in a Novel Way TORONTO, September 21, 2021 FSD Pharma ...
Acquisition Advances Company’s Strategic Plan Toward a Diversified Novel Drug Development Pipeline in Psychedelics and Medical Cannabis DENVER, Colo.,– August ...